Methods for the treatment of psoriatic arthritis using apremilast
US9872854B2 · kind B2 · utility
1Cited by
26References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 13, 2014 |
| Grant date | Jan 23, 2018 |
| Priority date | — |
| Expiry date | May 29, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating, managing or preventing psoriatic arthritis are disclosed. Specific methods encompass the administration of apremilast, alone or in combination with a second active agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.